When was Schrodinger founded?

Schrodinger was founded in 1990 and raised its 1st funding round 17 years after it was founded.

Where is Schrodinger located?

Schrodinger is headquartered in New York City, United States. It is registered at Portland, Oregon.

How many employees does Schrodinger have?

As of Aug 31, 2026, the latest employee count at Schrodinger is 997.

Is Schrodinger a funded company?

Schrodinger is a funded company, having raised a total of $162M across 9 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jan 01, 2007.

How much is Schrodinger worth?

The last known valuation of Schrodinger was $***** as of May 14, 2020.

When was the latest funding round of Schrodinger?

Schrodinger's latest funding was a $***** Grant (prize money) round on Nov 18, 2021, with participation from 1 investor.

What is the annual revenue of Schrodinger?

Annual revenue of Schrodinger is between $100M and $500M as on Dec 31, 2025

Where does Schrodinger rank among its competitors?

Schrodinger ranks 1st amongst 328 active competitors, of which 101 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was CuspAI, which secured $450M in Jul, 2026.

Who are the top competitors of Schrodinger?

Schrodinger's top competitors include Recursion Pharmaceuticals, Relay Therapeutics and Atomwise. Among them, CuspAI secured the most recent funding round in July, 2026.

Schrodinger - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Provider of a web-based simulation and modelling tool for computational chemistry and drug discovery. It has developed a software solution for computational chemistry and material designing. Its proprietary platform is a simulation-based modelling platform that offers protein-protein docking, protein modelling, protein engineering, and antibody modelling study. It also offers products that help in treating oesophageal, ovarian, pancreatic, breast, and lung cancers.

Website: www.schrodinger.com/
Social
Email ID: *****@schrodinger.com
Phone Number: +1 **********
Registered Address: Portland, Oregon

Key Metrics

Founded Year

1990

Location

New York City, United States

Stage

Acquired

Total Funding

$162M in 9 rounds

Latest Funding Round

Grant (prize money), Nov 18, 2021, $*****

Last Known Valuation

$***** as on May 14, 2020

Investors

Gates & 17 more

Ranked

1^st among 328 active competitors

Annual Revenue

$100M - $500M as on Dec 31, 2025

Employee Count

997 as on Aug 31, 2026

Investment & Acquisitions

Ajax & 5 more

Similar Companies

Recursion Pharmaceuticals & 330 more

Exit Details

Acquired by Baron Funds (May 18, 2020)

View Schrodinger's full profile

Schrodinger is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
DINGER GmbH CIN: B1601_HRB220765 , Germany, Active		-	-
SCHRODINGER, INC. CIN: 954284541 , United States, Active	Dec 26, 999	$100M - $500M (As on Dec 31, 2025)	652 (As on Dec 31, 2024)	-

Schrodinger got acquired by Baron Funds on May 18, 2020.

Click here to take a look at Schrodinger's acquisition in detail

Schrodinger has raised a total funding of $162M over 9 rounds. Its first funding round was on Jan 01, 2007. Its latest funding round was a Grant (prize money) round on Nov 18, 2021 for $*****. 1 investor participated in its latest round. Schrodinger has 16 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of Schrodinger:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 18, 2021	9134554	Grant (prize money)	6287911	2113658	2758220	4942550
May 21, 2019	8331247	Series D	6306209	9730583	5927779	Deerfield & 6 more
Jun 19, 2015	1815383	Series C	3618500	1684943	4348423	4538957

Access funding benchmarks and valuations. Sign up today!

View details of Schrodinger's funding rounds and investors

The founders of Schrodinger are William A Goddard and Richard A Friesner.

Here are the details of Schrodinger's key team members:

William A Goddard: Co-Founder of Schrodinger.
Contact Info: 1 email address
Richard A Friesner: Co-Founder of Schrodinger.
Contact Info: 1 email address

View details of Schrodinger's Founder profiles and Board Members

Schrodinger's employee count trend

Schrodinger has 997 employees as of Aug 26. Here is Schrodinger's employee count trend over the years:

Uncover Schrodinger's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Schrodinger include Recursion Pharmaceuticals, Relay Therapeutics and Atomwise. Here is the list of Top 10 competitors of Schrodinger, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Schrodinger 1990, New York City (United States), Acquired	Provider of a web-based simulation and modelling tool	$162M	HTIF, Laurion Capital & 16 others	74/100
2nd	Recursion Pharmaceuticals 2013, New York (United States), Public	AI-enabled drug discovery and development platform for novel therapeutics	$452M	Baillie Gifford, Felicis Ventures & 47 others	72/100
3rd	Relay Therapeutics 2016, Cambridge (United States), Public	Developer of drug discovery platform and study protein motion	$520M	BVF Partners, SoftBank Vision Fund & 17 others	70/100
4th	Atomwise 2012, San Francisco (United States), Series B	Developer of artificial intelligence platform for small molecule drug discovery	$219M	DCVC, B Capital & 27 others	67/100
5th	Valo Health 2019, Boston (United States), Series B	AI-powered platform for drug discovery and development	$450M	PSP Investments, Koch Disruptive Technologies ... & 7 others	67/100
6th	XtalPi 2014, Cambridge (United States), Public	AI-based drug research and development company	$785M	SoftBank Vision Fund, Orbimed & 25 others	67/100
7th	Isomorphic Labs 2021, London (United Kingdom), Series B	Digital platform focused on revolutionizing drug discovery using AI	$2.7B	Thrive Capital, CapitalG & 6 others	64/100
8th	PhaseCraft 2019, Bristol (United Kingdom), Series B	Provider of quantum simulation systems	$56.4M	UCL Technology Fund, LocalGlobe & 11 others	64/100
9th	CuspAI 2024, Cambridge (United Kingdom), Series B	AI-enabled platform for materials research and applications	$670M	New Enterprise Associates, Temasek & 33 others	63/100
10th	Xaira 2023, San Francisco (United States), Series D	AI-enabled platform for drug discovery and development	$1B	Arch Venture Partners, Foresite Labs & 11 others	63/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Schrodinger's competitors? Click here to see the top ones

Schrodinger has not made any acquisitions yet. Schrodinger has made 6 investments.

Here is the list of latest three $investments:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
May 13, 2024	Investments	Ajax	2019	Cambridge (United States)
Jun 01, 2021	Investments	Ajax	2019	Cambridge (United States)
Sep 17, 2018	Investments	Morphic Therapeutic	2015	Waltham (United States)